The chief investigator, Kalil, mentioned baricitinib to be tried in combo with Remdesivir on The Situation Room with Wolf Blitzer. Leronlimab is still under the radar with the decision-makers. We somehow need to break through into much greater public awareness.
Market Data 
Markets 
AI
